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SignalingLung epithelial cells use remarkably adaptive sensing and signaling systems to maintain a physiological state
supporting gas exchange and minimizing environmental insults. One facet of epithelial adaptability is the
reversible acquisition of mesenchymal features, a process termed epithelial–mesenchymal transition (EMT).
Although in the adult, permanent and complete EMT appears rare or non-existent, a growing body of evidence
implicates a critical role for the activation of EMT signaling in tissue remodeling, including ﬁbrotic lung disease.
The speciﬁc phenotypes of cells undergoing EMT re-programming during epithelial responses to injury continue
to bedeﬁned and are reviewedhere. Several recent studies implicate epithelial expression of canonical EMT tran-
scription factors, such as Snail and Twist1, with the acquisition of a less differentiated, more proliferative
stem-like state, providing an additional link between activation of EMT signaling and tissue repair. In lung air-
ways, proliferating variant clara cells rely upon Snail for effective epithelial repair, and in the breast, cells
possessing the greatest regenerative capacity also express Snail2. The ongoing elucidation of signaling underly-
ing epithelial stem/progenitor expansion coincides with recent discoveries implicating regenerative activity in
the lung, possibly including de novo regeneration of airway and alveolar units. It remains largely unknown
what signals drive organization of epithelial progenitor cells that expand after lung injury, to what degree
such organization is ever functionally relevant, and whether the lung regenerative potential recently observed
in mouse models extends to humans. Yet these unknowns with clinical potential bring future mechanistic stud-
ies of EMT and lung repair directly into the ﬁeld of regenerative medicine. This article is part of a Special Issue
entitled: Fibrosis: Translation of basic research to human disease.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
In addition to its position in an architectural arrangement critical
to gas exchange, the lung epithelium serves the major functions of
maintenance of an effective barrier against untoward ﬂuid accumula-
tion and protection of the lung from environmental insult. This biolo-
gy involves both local constitutive activities of the epithelium such as
ciliated movement, secretion of surfactants, and anti-bacterial pep-
tides as well as sensing functions that endow the lung with the capac-
ity to respond to potentially injurious foreign agents. In the past
decades, numerous pathways of epithelial signaling have been eluci-
dated that help explain the capacity of the lung to mount host defense
against such diverse insults as infectious agents, oxidative stress, par-
ticulate matter, and leakage of blood components into the airway and
alveolar compartments [1–7]. Defects in any of the epithelial defense
systems are a source of pathology. Indeed there is increasings: Translation of basic research
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l rights reserved.attention on the epithelium as both a site of disease initiation and a
driver of disease progression [8]. In no small part this attention de-
rives from increased understanding of the molecular mechanisms
by which the epithelium maintains homeostasis and how injury
leads to dysfunction that promotes disease.
The multifaceted defense systems of the epithelium are fully inte-
grated into the complicated architecture of the lung and the innate
and adaptive immune systems that operate to both respond to the epi-
thelium and to effect inﬂammatory responses designed to resist infec-
tion [5,9]. A number of recent reviews summarize current thinking
about how the epithelium interfaces with the immune system in
defense of the lung and its role in common disorders such as asthma
[10–12]. There are also a number of comprehensive reviews of the
diverse signaling pathways by which the lung epithelium responds to
injurious signals, in part to promote repair [13–15]. An important and
evolving area of epithelial biology in the adult is the degree to which
epithelial plasticity contributes to tissue repair and remodeling. By epi-
thelial plasticity ismeant the capacity for epithelial cells to change from
one state of differentiation to another, either transiently or more
prolonged, in a regulated manner [16]. One such change is epithelial
to mesenchymal transitions (EMT) in which epithelial cells lose strong
mediators of cell:cell contacts such E-cadherin (adherens junctions)
and ZO-1 (tight junctions) and instead begin to express mesenchymal
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reviewwewill highlight recent studies that continue to deﬁne the biol-
ogy of EMT as it relates to tissue repair, the relationship of EMT to epi-
thelial stem/progenitor cell function, and consider recent evidence
that lung injury resolution also includes regeneration of new airway
and alveolar structures.2. Evolution of the concept of epithelial–mesenchymal transition
2.1. Development
Though the phenomenon of epithelial cells acquiring mesenchymal
features during embryogenesis has been noted for over a century, the
term epithelial–mesenchymal transition (EMT) arose in the 1980s in
reports primarily from the ElizabethHay lab [19]. A compelling example
of EMT comes from studies of gastrulation, a stage in embryonic devel-
opment transitioning from the single cell layer blastula to the gastrula,
comprised of the 3 major cell layers for subsequent organogenesis:
endoderm, ectoderm, and mesoderm [18]. A mesenchymal trans-
differentiation of epiblasts (termed mesendodermal cells) of the early
Drosophila blastula is needed to initiate the process of gastrulation.
This is preceded by the appearance of the transcription factors Snail1
and then Twist on a restricted domain of the ventral blastula [20].
Snail1 was identiﬁed as a transcriptional repressor whose major func-
tion is to inhibit the expression of non-mesodermal elements such as
E-cadherin, thereby deﬁning the spatial territory of mesodermal initia-
tion [21]. In the ﬂy, expression of Twist is also required for gastrulation
and the lineage switch of epithelial to mesenchymal cell fate. Twist is
not only a repressor but also directly promotes activation of a number
of mesenchymal genes [22]. Other transcriptional repressors such as
goosecoid are expressed in this gastrulation organizer region and sup-
port this process [18]. The ingress of this collection of Snail-expressing
cells into the primitive endodermal mass initiates the formation of the
mesodermal layer and generation of almost the entirety of mesenchy-
mal structures such as skeleton, cartilage, and bone in the mature or-
ganism. Snail and Twist empower the ingressing cells to dissociate
and migrate to form mesodermal structures. Many of the cardinal
events and signaling programsmediating gastrulation appear to be con-
served from Drosophila to humans. But gastrulation is not the only
developmental process requiring EMT. Formation of the cardiac valves
has been well studied as a process involving an EMT of the epicardial
cells (derived from the mesodermal layer). Mesenchymal elements
such as the peripheral nervous system of the adult organism also derive
from neural crest cells that are epithelial in nature and undergo EMT via
signaling reminiscent of gastrulation [18]. Mice homozygous for dele-
tion of Twist die at E11.5 with failure of neural tube closure and numer-
ous mesenchymal defects [23]. A thorough discussion of the many
facets of development involving EMT biology has been previously pub-
lished [18,24]. The concept of EMT thus emerged as a developmental
program for a complete transdifferentiation of cells from an epithelial
tomesenchymal phenotype, sometimes temporary and sometimes per-
manent, but apparently crucial for organogenesis. Although signaling
leading to induction and maintenance of EMT at the various stages of
development is quite complicated, involving induction or repression
of numerous transcription factors, a relatively small set of transcription
factors can be viewed as principally driving EMT: Snail1, Snail2 (Slug),
Twist1, Zeb1/2, E12/E47, and Goosecoid. It is worth noting that FGF
receptor signaling is important for sustaining and organizing themeso-
derm following mesodermal initiation and may have a similar function
in adults [25,26]. There is no evidence of EMT during lung development
and no known requirement for any of the principal EMT transcription
factors for branching morphogenesis or maturation of airway epithelial
lineages during development. Indeed sustained activation of TGFβ1, a
major inducer of the EMT program in adults, markedly suppresses
embryonic development of airways and alveoli [27].2.2. Cancer and EMT
That EMT biology is relevant in the adult derives from a series of
observations, beginning with a report in 2000, indicating that human
carcinomas (epithelial tumors) frequently express one or more of the
principal EMT transcription factors. Snail1 was initially identiﬁed
in a number of epithelial tumor cell lines as a direct repressor of
E-cadherin transcription [28]. Two groups then demonstrated that
breast carcinomas frequently express Snail1 and moreover that the
expression of Snail1 and downregulation of E-cadherin transcription
developed in invasive regions of breast tumors and in metastatic nests
within lymph nodes [29,30]. Snail1 directly suppresses E-cadherin tran-
scription in carcinomas and in turn repression of E-cadherin correlates
with and in part mediates the development of a mesenchymal pheno-
type. Expression of Snail1 and/or Snail2 (also termed Slug) is now
linked to metastasis and outcome in numerous carcinomas including
breast, ovary, colon, and lung [31–34]. Twist1, in addition to Snail, is
also strongly linked tometastasis and outcome in numerous carcinomas
[35]. Twist expression induces an EMT phenotype that includes not only
loss of cell:cell contacts via disruption of adherens junctions but also
the development of altered protease expression and cytoskeletal re-
organization that collectively promote increased cell motility and
tumor invasion across basement membranes [22]. There is accumulat-
ing evidence that the activation of an EMT program and acquisition of
an EMT phenotype is important to tumor invasion and metastasis
[17,36]. The functional effects of Snail1 and Twist on tumor cells is obvi-
ously reminiscent of their effects during mesodermal development, but
permanent or even temporary complete transition of carcinomas to a
mesenchymal cell appears to be unusual [37,38]. Much more common
is the temporary acquisition of mesenchymal features, sometimes
referred to as partial EMT, at sites of tumor invasion into surrounding
normal tissue and the vasculature [39,40]. The loss of epithelial and
acquisition of mesenchymal features in this context appears strongly
dependent on the cardinal EMT transcription factors, justifying the con-
tinued use of the term EMT applied to tumor biology.
An important feature of carcinomas is the ﬁbroblast-rich stromal
milieu surrounding and inter-digitated with tumor cells. Consistent
with enhanced plasticity rather than lineage switch as a primary con-
sequence of activation of the EMT program in cancer, there is little
evidence that cancer-associated ﬁbroblasts derive from the epithelial
tumors themselves. Rather, an extensive crosstalk between tumor
cells and activated stromal ﬁbroblasts contributes to the invasive phe-
notype of tumors [41]. On the one hand cytokines such as TGFβ1 and
PDGF, derived either from tumor cells or macrophages recruited to
the tumors, activate stromal ﬁbroblasts to not only proliferate but also
produce more TGFβ1, supporting further expansion of the stromal
ECM. Cytokines derived from activated stromal ﬁbroblasts such as
hepatocyte growth factor and Wnts then directly promote growth and
invasion of the tumors. The stiffness acquired by an expanding ECM
appears to secondarily further promote tumor invasion as the extent
of stromal collagen is a strong prognostic indicator for carcinomas
[42]. The molecular details of tumor–stromal crosstalk may parallel
the epithelial–stromal interactions found during tissue remodeling;
certainly tumor–stromal interactions elucidated by studies of tumor
progression are a roadmap for further inquiry into the molecular path-
ways by which epithelial cells regulate tissue remodeling.
2.2.1. EMT promotes cancer cell survival
One relevant pathway of activation of the tumor EMT program is
signaling via PDGF receptors. PDGF binding to its receptor is reported
to activate Src kinase within breast tumors that then induces expres-
sion of Twist [43]. Twist functions not only to induce loss of tumor
epithelial markers and acquisition of a mesenchymal phenotype but
also to promote tumor survival and senescence resistance. Twist at
least in part is reported to block oncogene-induced premature senes-
cence, a possible consequence of a burst of epithelial proliferation, by
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p21/cip [44]. Similarly, both Twist and Snail have been reported in
some cell systems to promote resistance to apoptosis [45]. Prolonged
exposure of mammary epithelial cells to TGFβ1 also leads to resis-
tance to apoptosis and a prolonged EMT state in vitro. [46]. Thus a
general feature of the EMT phenotype appears to include promotion
of epithelial survival and senescence resistance.
Promotion of resistance to premature senescence may be relevant
to situations in the lung where the EMT program is activated. There is
accumulating evidence that epithelial endoplasmic reticulum (ER)
stress is a common predisposing event for development of Idiopathic
Pulmonary Fibrosis (IPF) [47]. Several recent studies of pulmonary
ﬁbrosis identify ER stress as a cause for activation of an EMT program
both in vitro and in vivo in mouse models [48,49]. Consistent with this
observation and the idea that EMT may promote resistance to stress,
strong upregulation of Twist1 and Snail1 has been observed in the
hyperplastic alveolar epithelium of IPF patients, an epithelia thought
to be under stress and susceptible to senescence [50–52].
2.3. EMT and lung injury
For the purpose of this review we use the term stem/progenitor
cells to represent cell populations in the lung capable of both exten-
sive self-renewal and differentiation into multiple organ-speciﬁc cell
types. More differentiated cells have limited self-renewal and can
only divide symmetrically or perhaps differentiate into a very limited
number of cell types. As an extension of this deﬁnition, it is thought
that stem cells, with the highest capacity for self-maintenance and
proliferation, have the greatest potential for repair/regeneration
after injury. A current model utilizing these deﬁnitions and depicting
the proposed roles of EMT in lung repair and ﬁbrosis is illustrated
in Fig. 1. Both mature, differentiated (open) and stem/progenitor
(solid) epithelial lining cells maintain tight cell:cell and cell:matrix
junctions, depicted in the ﬁgure by the cortical distribution of actin
that strengthens such contacts. Injury to the lung epithelium occurs
at many distinct anatomical sites and the temporary acquisition of
mesenchymal features, depicted by ﬂattened cells with stress ﬁbers
in Fig 1, after injury is common. For example, denudation of tracheal
or conducting airway epithelium leads rather quickly to a squamous
phenotype as the remaining epithelial cells spread and migrate over
large surfaces to provide an intact lining layer [15,53]. This is followed
by regeneration of the major, fully differentiated epithelial cell types
normally present in the tracheal wall. There is no evidence to date
that this actually represents temporary activation of an EMT program
even though mesenchymal features, including vimentin, transiently
appear in the migratory cells, but some degree of activation of EMT
signaling is likely. Indeed a recent study provided evidence that
enhanced β-catenin signaling in airway basal cells leads to their pro-
liferation and acquisition of mesenchymal features, including expres-
sion of Snail1 and suppression of E-cadherin. This signaling response
promoted epithelial regeneration following injury [54]. The conver-
sion of alveolar type II cells to type 1 cells on the other hand involves
a very large increase in surface area and change in cell shape, but
there are no mesenchymal features and no evidence that an EMT pro-
gram is involved. Although there are few studies in lung, studies of
wound healing in the skin reveals the activation of Snail2 and EMT
markers at the leading edge of epithelial migration, indicating a tran-
sient EMT-like response of keratinocytes [55]. Indeed Snail2 expres-
sion in keratinocytes was required for their migration and efﬁcient
wound repair [56]. A recent study of repair after naphthalene-
induced distal airway injury indicates similar biology [25]. After
naphthalene injury, the surviving clara cells produce Wnt7b, which
induces robust proliferation of parabronchial smooth muscle cells,
accompanied by their increased FGF10 production. FGF10 was
shown to be necessary and sufﬁcient for this repair process, as ectopic
overexpression of FGF10 allowed for efﬁcient repair even in theabsence of Wnt ligands. Interestingly, FGF10 signaling induced
expression of clara cell Snail1 and activation of an EMT program,
with reduction in E-cadherin expression and induction of α-SMA
and vimentin. Speciﬁc deletion of Snail1 in clara cells conﬁrmed the
importance of transient EMT to clara cell expansion and repopulation
of the injured epithelium. Thus varying degrees of an EMT phenotype
driven by classical EMT transcription factors are likely common after
epithelial injury and may contribute importantly to normal regenera-
tion of intact epithelial barriers.
2.3.1. EMT in ﬁbrotic disease
Many prior studies have linked evidence of EMT with pathological
tissue ﬁbrosis, but whether epithelial cells undergoing EMT directly
contribute to the ﬁbroblast pool or whether activation of an EMT pro-
gram indirectly regulates ﬁbrosis via intercellular signaling is uncer-
tain. Therefore the question of how EMT affects tissue ﬁbrosis is
central to the ﬁeld. Initial studies implied that a signiﬁcant fraction,
perhaps as much as 30–40% of ﬁbroblasts/myoﬁbroblasts in models
of kidney, liver, and lung ﬁbrosis derive directly from epithelial cells
[57–60]. But this conclusion is largely based on in situ immuno-
co-localization of cells bearing a lineage trace of epithelial origin
(frequently β-galactosidase) with a mesenchymal marker, most typi-
cally α-smooth muscle actin. Cells of epithelial origin expressing
some degree of α-smooth muscle actin (or collagen) may or may
not be true myoﬁbroblasts. Indeed more recent reports question
such co-localization and indicate few if any myoﬁbroblasts appearing
during ﬁbrogenesis derive from epithelial cells [61–64]. In some
authors' view this means EMT does not occur during tissue remodel-
ing. In the lung, a recent report provided convincing evidence that the
bulk of increased mesenchymal markers and ECM proteins in the
bleomycin model of ﬁbrosis do not come from mature alveolar type
II cells [64]. On the other hand there is abundant evidence that an
EMT-like transcriptional program is activated following major injury
to liver, kidney, or lungs in mice and there is evidence that during
either orderly repair or ﬁbrogenesis epithelial cells express mesen-
chymal proteins, including α-smooth muscle actin and collagen1. In
addition to evidence by immunostaining, ﬂow cytometry conﬁrmed
that a small percentage of primary lung epithelial cells isolated by
ﬂow cytometry from mouse lungs 17 days after bleomycin injury
express mesenchymal proteins including collagen1, vimentin, and
α-SMA [65]. Alveolar epithelial cells freshly isolated from lungs of
IPF patients also express mesenchymal proteins, unlike normal lung
epithelia [66,67]. Recently, epithelial cells with basal cell-like markers
sandwiched between the overlying alveolar epithelium and underly-
ing ﬁbroblastic foci in biopsies of IPF patients were shown to express
mesenchymal proteins as well as diminished E-cadherin, implying
activation of an EMT program [68]. How these cells may contribute
to IPF pathobiology is unexplored.
Although epithelial cells are not the major source of collagen dur-
ing ﬁbrogenesis, there are now several studies indicating that block-
ade in vivo of the EMT program in liver, kidney, or lung mouse
models strongly attenuates injury-induced ﬁbrosis. For example,
selective deletion of Snail1 in liver hepatocytes (an epithelial cell)
virtually ablates increases in liver collagen following a relevant
ﬁbrogenic stimulus, carbon tetrachloride poisoning [69]. Likewise,
deletion of the integrin α3 speciﬁcally in pulmonary epithelial cells,
which is required for EMT in the distal airway/alveolar epithelium,
markedly attenuates collagen accumulation after bleomycin-induced
lung injury [70]. In the kidney, attenuation of the EMT program
with a peptide BMPmimic abrogates excessive collagen accumulation
in several models of kidney ﬁbrosis [71]. These results underscore the
point that EMT in the adult is not mainly a source of ﬁbroblasts/
myoﬁbroblasts but a reprogramming of epithelial cells toward a
mesenchymal phenotype that inﬂuences aspects of epithelial behav-
ior important to the injury response. It is appealing to hypothesize
that activation of an EMT program following signiﬁcant injury is
Fig. 1. Overview of the roles of EMT in epithelial responses to injury. Epithelial cells (open) and epithelial stem/progenitor cells (ﬁlled) both respond to EMT-inducing stimuli with
expression of classical EMT transcription factors leading to reprogramming from a mature epithelial phenotype, highlighted by a cortical distribution of actin (thin lines), toward a
mesenchymal phenotype. Numerous co-factors and inputs from signaling pathways not illustrated in the ﬁgure also contribute to the overall EMT phenotype [18], that includes not
only expression of mesenchymal proteins but also altered signaling that affects proliferation, senescence, accumulation of monocyte/macrophages, and crosstalk with resident mes-
enchymal cells in the injured area. The relative contribution and degree of expansion of stem/progenitor cells likely depends on the extent of cell death and disruption of basement
membranes. Regeneration and ﬁbrosis are depicted as overlapping but inversely proportional outcomes.
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cell expansion, but once activated the downstream signaling is
susceptible to excessive responses with mesenchymal expansion
(leading to ﬁbrosis). The protective outcome from blockade of EMT
implies that, overall, the ﬁbrogenic effects of EMT may outweigh the
beneﬁts, at least in these models of ﬁbrosis. Clearly, mechanisms by
which activation of the EMT program modulates tissue ﬁbrosis need
further clariﬁcation.
2.3.2. TGFβ1 as an important mediator of EMT
Among the initiating events leading to activation of an EMT
program in Fig 1, the dominant and most consistently implicated
pro-ﬁbrotic cytokine is TGFβ1 [72]. However, TGFβ1 activation and
signaling is context dependent: activation of latent TGFβ1 requires
activation of αV integrins that bind latent TGFβ1 and is thus regulat-
ed by outside-in integrin signaling. Moreover, TGFβ1 activation and
Smad phosphorylation alone is insufﬁcient for EMT. Progression
toward EMT is dependent on activation of additional co-factors that
direct Smad signaling toward induction of the cardinal EMT transcrip-
tion factors. For example, the EMT pathway is empowered by loss of
cell contacts that promote concurrent Src activation and formation
of β-catenin/Smad complexes [70,73,74]. Concurrent activation of
other non-Smad signaling pathways including Jun kinase and AKT/
mTOR also seem required for induction of the full EMT program. A
particularly interesting pathway of activation of EMT is expression
of metalloproteinase 3 (MMP3). MMP3 expression is linked to both
proteolysis of cell surface contacts and activation of an alternative
Rac1 isoform (Rac1b) via reactive oxygen species that then leads to
activation of the EMT program [75]. Implicit in these modulatory pro-
cesses is that activation of an EMT program requires signiﬁcant injury
or insult and frequently epithelial cell death. Consistent with this
premise are several reports identifying viral infection of epithelial
cells or the presence of tissue hypoxia as potent inducers of EMT.
Hypoxia-inducible factor 1α binds to both Snail and Twist promoters
[76,77].
2.3.3. mIRs in EMT
The transcriptional reprogramming initiated by the major EMT
transcription factors is supported by much lower levels of miR200family members whose expression promotes epithelial differentiation
and whose repression via TGFβ1 induction of Zeb1/2 favors EMT
[78,79]. A number of other microRNAs also very likely regulate EMT
reprogramming and ﬁbrosis [80]. One of these, miR29, a known repres-
sor of collagenous proteins, was recently reported to block bleomycin-
induced lung ﬁbrosis [81].
2.3.4. ER stress induces EMT
Several recent studies point to the role of ER stress in activating
EMT and promoting pulmonary ﬁbrosis [48,49,82]. Expression of
either of two mutant surfactant C (SPC) proteins previously linked
to pulmonary ﬁbrosis was found to initiate both an unfolded protein
response and EMT in vitro. Both studies reported activation of Src
kinase by ER stress as being required for induction of EMT [48,82].
Lawson and colleagues also found ER stress induced by transgenic
expression of one of these SPC mutations (L188Q) speciﬁcally in the
lung epithelium synergized with doses of bleomycin too low to initi-
ate ﬁbrosis alone to promote signiﬁcant ﬁbrosis in combination
[49,83]. The L188Q SPC mutation used in these transgenic mice to
generate ER stress had been previously reported to accumulate in
the ER of cultured cells [48]. Collectively, these studies highlight a
connection between ER stress, activation of the EMT program, and
human mutations unequivocably linked to ﬁbrotic lung disease.
2.4. EMT phenotypes
Activation of the EMT program appears to be a common response
to epithelial injury with the potential to inﬂuence several facets of the
injury repair response beyond altered cell:cell adhesion and motility
(Fig 1). The observation that activation of the EMT program in variant
clara cells is associated with expansion of this stem/progenitor cell
airway population in the lung is consistent with recently reported
ﬁndings in normal mammary epithelial cells induced to express
Snail2. Guo and colleagues reported that expression of Snail2 and
Sox9 by viral transduction in normal cells strongly promoted expansion
of de-differentiated cells capable of long termmammary reconstituting
activity in vivo [84]. This work extends prior studies from this group
connecting EMT signaling in tumor cells with stem cell function. Breast
cancer cells that acquire a mesenchymal phenotype through EMT
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of surface markers typical of stem cells and enhanced mammosphere
formation in culture, a bioassay for stemness [84,85]. Aggressive sub-
types of breast cancer, such as basal-like breast cancers, are enriched in
cells with stem cell features, including activation of the EMT program.
These ﬁndings are consistent with studies of various carcinomas sup-
porting a role for reversible EMT in expansion of cancer stem/progenitor
cells [86]. Thus, in both wound repair and carcinomas, cells with an acti-
vated EMT program frequently bear not only mesenchymal features but
features of relatively undifferentiated cells supporting the view that one
function of the EMT programmay be to stabilize and/or expand progen-
itor cell populations.
In addition, in a model of carbon tetrachloride induced hepatic
ﬁbrosis, deletion of Snail1 speciﬁcally in hepatocytes markedly attenuat-
ed theproduction of pro-inﬂammatory cytokines in the liver, attenuating
monocyte/macrophage accumulation and numerous markers of inﬂam-
mation as well as ﬁbrosis [69]. Marked attenuation of the inﬂammatory
response was also reported in a model of cutaneous inﬂammation
involving Snail2 deﬁcient keratinocytes [87]. These ﬁndings suggest
that the cardinal EMT transcription factors Snail1 and 2, expressed in
epithelial cells after injury, are also implicated in regulation of innate
immunity, an important facet of tissue repair [88].
2.4.1. Paracrine signaling through EMT
EMT appears to promote mesenchymal expansion through multi-
ple mechanisms. Recent structural studies of TGFβ1 activation sup-
port the idea that TGFβ1, once activated on an αV integrin, can
release from the integrin and diffuse to surrounding cells in a para-
crine signaling pathway [89]. Activation of TGFβ1 on epithelial cells
is crucial to ﬁbrogenesis in the lung and paracrine TGFβ1 signaling
to resident mesenchymal cells via this pathway is likely. Release of
other cytokines known to activate ﬁbroblasts and promote their pro-
liferation, such as PDGF, may also be important. In addition, signals
from activated epithelial cells may recruit bone marrow derived
cells, especially monocytes/macrophages, into the lung that in turn
contribute to ﬁbroblast activation and expansion. Prior studies have
demonstrated that macrophages are a major source of PDGF and insu-
lin growth factor-1 mRNAs in the lungs of patients with IPF [90].
Unlike in the liver and skin, there are no studies as yet addressing
whether epithelial Snail is important for monocyte/macrophage
recruitment after lung injury. Finally, expression of ECM components
directly by epithelial cells likely contributes to ECM deposition and
ﬁbrogenesis. It is unclear how or whether the expression of mesen-
chymal proteins themselves affects the behavior of epithelial cells
after injury, but enhanced motility, survival, and integrin signaling
are all possible downstream consequences of secretion of additional
matrix proteins by epithelial cells. It also remains to be clariﬁed
whether mature or stem/progenitor epithelial cells in the lung can
in fact become permanent or prolonged collagen1-producing cells.
2.4.2. EMT regulates the dynamic balance between ﬁbrosis and
regeneration
As depicted in Fig 1 and discussed above, a balance between ECM
deposition/tissue remodeling and stem/progenitor cell expansion and
differentiation is likely a major determinant of whether epithelial
injury is followed by orderly repair or ﬁbrosis. The success of regener-
ation or the predominance of ﬁbrogenesis appears inversely related.
Replenishment of the epithelium from progenitors proliferating
along preserved basement membranes has long been thought to be
a critical determinant of lung repair [15]. But recent studies point to
the capacity for more extensive involvement of epithelial progenitors
for regeneration including forming new structures in more severely
injured lung areas as the lung attempts to recover, both in airways
and in alveoli. These results invite further testing of the role of EMT
in regulating both the pluripotential state of resident stem/progenitor
cells in airways and alveoli and their expansion following injury. Asreviewed in the next section, such studies are empowered by recent
evidence further deﬁning the types of stem/progenitor in the adult
lung.
3. Epithelial stem/progenitor cell expansion and alveolar
regeneration after lung injury
In comparison to the well-characterized cellular hierarchies of the
hematopoietic system or solid tissues like the intestine or mammary
gland, understanding of lung stem cells is still in its infancy. This
can be attributed in part to the relatively slow turnover rate in the
lung, on the order of 3–5 months in mice, whereas the gut, for
instance, undergoes complete replacement of the epithelial lining in
a matter of days. Classical experiments using nucleotide label reten-
tion to identify slow-cycling cells, once considered the most universal
marker of stem cells, cannot be easily interpreted in the lung as the
majority of epithelial cells are long lived. As a result, most information
on lung lineage hierarchy comes from injury models, inducing prolif-
eration and differentiation of resident stem cells [91–94].
3.1. Facultative regenerative capacity of differentiated lung epithelial
cells
The earliest, and probably least controversial, description of a lung
progenitor cell population was the observation that alveolar type II
cells divide asymmetrically to both self-renew and give rise to type
I pneumocytes after NO2 injury [95]. This is a generally accepted phe-
nomenon and to date represents the only deﬁnitive instance of alve-
olar progenitor cell differentiation into more specialized descendants.
The recent development of in vivo ﬂuorescence-based lineage tracing
methods for type II cells has allowed the long-predicted type II to type
I cell conversion to be graphically visualized in situ (Fig 2). Following
injury and epithelial cell death the expansion of existing type II cells
within the alveolar compartment and their replenishment of type I
cells is evident [64]. It is still formally possible that not all SPC+
type II cells are equivalent and proliferation and type I cell replenish-
ment emanates from a pre-existing but indistinct subpopulation of
type II cells. This point will require further study.
Similarly, clara cells have long been known to harbor regenerative
potential for airway (bronchiolar) epithelium and evidence favors
the existence of subpopulations within this cell pool. Experiments
employing NO2 and naphthalene demonstrated that clara cells prolif-
erate to replace the denuded bronchiolar epithelium; in addition to
symmetric division, clara cells were shown to differentiate into ciliat-
ed cells as well [96]. Later work demonstrated that only a subpopula-
tion of clara cells are capable of surviving injury and repairing the
airway; these cells were shown to be associated with two anatomical
niches: neuroendocrine bodies scattered throughout the airway, and
bronchio-alveolar duct junctions (BADJ) at terminal bronchi [97].
While certainly possessing self-renewal andmultipotent differentiation
capacity, variant clara cells and type II pneumocytes were thought to be
responsible for reconstitution of only their immediate anatomical
region, i.e. the airways and alveoli, respectively.
3.2. Dedicated stem/progenitor populations in the lung
The paradigm of distinct regional progenitors was challenged by the
identiﬁcation of cells at the bronchoalveolar duct junction (BADJ) that
possess lineage markers for both type II cells (SPC) and clara cells
(CC10, alternatively known as Scgb1a1 or CCSP) [98]. Isolation of
these bronchioalveolar stem cells (BASCs) via ﬂow cytometry revealed
their in vitro potential to give rise to both clara and alveolar type II
cells, raising the intriguing possibility that these cells might act as a
“master” progenitor for both bronchiolar and alveolar epithelium. In
support of this interpretation is the fact that these cells expand in
multiple injury models and upon induction of Kras expression [98].
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complicated. Lineage tracing utilizing a genetic tag of CC10-expressing
cells and their progeny in an SO2 model revealed no evidence of BASC
contribution to the repair of alveolar epithelium, despite efﬁcient label-
ing of virtually all CC10-expressing cells. The pattern of labeled cells in
repaired epithelium also suggested that rather than being a spatially
restricted subpopulation of variant clara cells, proliferative clara cell
progenitors are scattered randomly throughout the airways [99]. More
recently, the same analysis of repair after more severe alveolar injury
induced by bleomycin demonstrated extensive labeling of type II and
type I alveolar cells. The parent CC10-expressing cell is still unclear,
as this model labels both BASCs and a small population of CC10-
expressing, pro-SPC+ cells within alveoli [64], indicating that dual pos-
itive CC10/pro-SPC+ cells are not unique to the BADJ regions. These
recent ﬁndings again raise the question of whether all type II cells are
capable of self renewal and type I cell conversion, or this biology is
mainly restricted to a subpopulation marked by low levels of CC10
co-expression.
The idea that repair mechanisms may fundamentally differ
depending on the degree of injury confronting the lung also emerges
from several recent studies addressing regenerative potential of epi-
thelial progenitors within the lung parenchyma. Our group reported
the existence of a heretofore unrecognized population of alveolar
cells expressing integrin α6β4 scattered throughout the lung paren-
chyma that express neither SPC nor CC10, and thus would not be
labeled in any of the described transgenic mice [100]. In vitro, when
plated on Matrigel, these cells formed colonies from single cells
that retained their mostly undifferentiated phenotype. Importantly,
when implanted under the kidney capsule alongside epithelial cell-
depleted embryonic lung mesenchyme, these cells incorporate into
the developing lung structures and develop three-dimensional struc-
tures reminiscent of alveolar saccules and small airways. Interesting-
ly, progeny of individual β4+ cells differentiate into structures that
are almost all exclusively either SPC+ or CC10+. This observation
suggests that while these cells are indeed multipotent, at least in
vitro, their in vivo differentiation is likely highly dependent upon
their microenvironmental context or niche. The size of the α6β4+
population was also shown to expand after bleomycin injury, further
suggesting an important role in repair [100]. Whether these cells
directly contribute to epithelial repair in vivo remains to be demon-
strated, as there is not yet a suitable mouse model for direct lineage
tracing of α6β4+ cells. However, using lineage tracing of SPC+
type II cells in the bleomycin injury model, large portions of the
repaired type II cell rich alveolar epithelium within the most injuredFig. 2. In vivo conversion of type II to type I cells. A lineage trace on murine alveolar type II c
gene and its activation in type II cells reported by GFP expression (green) [100]. Type II ce
expressing GFP. The section is from a lung 17 days post bleomycin and illustrates a rela
walls in the absence of SPC conﬁrms type II to type I cell conversion. Virtually no conversioregions of the lung remained unlabeled, indicating that an SPC nega-
tive stem/progenitor cell must be contributing to the repair of the
more injured regions.
3.3. Lung progenitors in injury and repair
The possibility of alveolar repair by expansion of CC10-negative /
SPC-negative stem/progenitor cells was also revealed in studies of a
mouse model of inﬂuenza infection [101]. Careful examination of
H1N1-infected mouse lungs revealed the existence of numerous
“pods” of epithelial cells that express markers of basal cells: p63
and cytokeratins 5 and 14 (Krt5/Krt14). Intriguingly, these markers
are restricted to the trachea in normal mouse lung and are virtually
never seen in uninjured airways or alveolar regions at steady state.
Single p63+ cells ﬁrst appeared in the airway and then later in the al-
veolar regions after injury. At later time points, these clusters spread
out and began to resemble alveoli-like structures. These structures at
later time points also stain positive using antibodies speciﬁc to alveo-
lar epithelium, although these antibodies are against unknown anti-
gens, making interpretation of the immunostaining limited. Cells
expressing these same markers could be indirectly isolated from
mouse and human lung and were present in greatly expanded
numbers after H1N1 injury. Lineage tracing using a Krt14 knock-in
mouse showed labeling of both bronchiolar and alveolar Krt5-
expressing cells, suggesting there is a concerted migration of these
cells from the bronchioles to the parenchyma. Unfortunately there
is yet to be direct evidence for descendents of the Krt5+ cells in
normal alveolar or bronchiolar structures after complete recovery,
so direct contribution of these p63/Krt5/14-expressing cells to the
repaired epithelium remains in question.
While demonstrating an exciting new phenomenon and hinting at
a previously unrecognized mechanism of lung repair, these studies
also present difﬁcult questions. Although Krt5 is an excellent marker
for these rapidly expanding epithelial clusters after injury, there is no
major cell type in the uninjured distal lung that expresses Krt5 or p63.
This invokes the obvious question of cell of origin. Perhaps variant
clara cells or BASCs are “activated” upon injurious stimuli and only
then begin to express these markers. If so, the p63+ cells appear to
lose CC10 and SPC expression. There is also the question of whether
these cells truly migrate from airways, or whether the temporal
appearance of “airway ﬁrst” simply reﬂects the kinetics of injury for
different cell types. In that case, one might expect α6β4+ alveolar
cells to serve as the source for alveolar Krt5+ pods. True migration
of these epithelial cells from the airway into the parenchyma wouldells was created by the insertion of a Cre recombinase into the endogenous mouse SPC
lls are immunostained for SPC (red) and cells that appear white are type II cells also
tively normal appearing alveolar region. Expression of GFP along the entire alveolar
n is discernible in this time period without injury.
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be deﬁned whether airway progenitors use EMT reprogramming,
analogous to variant clara cells following naphthalene injury, to
migrate and regenerate alveolar structures.
3.4. Novel mechanisms and signaling implicated in lung regeneration
The ﬁnding that progenitor cells from the adult lung can form lung
structures in the kidney capsule organoid assay and in mouse lungs
after inﬂuenza infection suggests new meaning to the term “regener-
ation”. Though the traditional concept of lung regeneration centers
around restitution of an effective and normal appearing epithelial
barrier layer [14], the newer ﬁndings raise the possibility that distal
airway and alveolar units could be formed de novo in response to
severe injury. This possibility is supported by two additional recent
studies examining the outcome of lung insult in the mouse. Like the
inﬂuenza model, pneumonectomy (PNX) in mice results in a regener-
ative process rather than ﬁbrosis. The remaining lung lobes not only
increase in volume but also in cellularity, suggesting new alveolar
structures are developing. Recent work has begun to elucidate the
mechanism of post-developmental alveologenesis, highlighting the
important role of pulmonary capillary endothelial cells (PCECs) [102].
After PNX, proliferating PCECs upregulate FGFR1, which in turn
(indirectly) phosphorylates VEGFR2. Endothelial cell-speciﬁc deletion
of VEGFR2 and/or FGFR1 abrogated proliferation of both PCECs and
alveolar type II cells as well as ablated the restoration of lung function
normally seen after PNX as measured by static compliance and inspira-
tory volume.
Microarray analysis of this PNX model revealed the unexpected
importance of metalloproteinase14 (MMP14), a membrane-bound
protease. MMP14 is known to be important in developmental
alveologenesis, although the mechanism is not well understood. In
the PNX model, it was shown that MMP14 is expressed by PCECs
and that it further induces proliferation of alveolar epithelial cells.
Ultimately, MMP14's mitogenic effect was shown to be due at least
in part to its capacity to proteolytically cleave cryptic EGF ligands,
increasing the bioavailability of these important growth factors.
Indeed, exogenous delivery of EGF to VEGFR2/FGFR1 knockout mice
restored lung mass and volume after PNX in these mice [102]. This
series of experiments not only highlights the importance of vascular
endothelium as a stem/progenitor niche, but also describes an impor-
tant new mechanism by which proliferative signals are imparted
upon epithelial progenitors. Whether the trifecta of VEGFR2,
FGFR1, and MMP14 is important for epithelial repair after drug or
pathogen-induced injury remains to be seen. Of note, evidence was
recently provided for airway/alveolar growth in a patient 15 years
post pneumonectomy, indicating lung regeneration may also occur
in humans [103].
Evidence of alveolar regeneration and crosstalk between vascular
and epithelial cells in the lung parenchyma was also recently reported
in a mouse model of smoking-induced emphysema [104]. In this study
the authors generated smoking-related emphysema over six months
using well established methods. They observed that vascular remodel-
ing and pulmonary hypertension preceded alveolar destruction. Both
emphysema and vascular remodeling were found to be dependent on
inducible nitric oxide synthetase (iNOS), though the important cellular
sources of nitric oxide were different in the two processes. Surprisingly,
even after established emphysema the authors provided evidence that
continued inhibition of iNOS, without further smoking-induced injury,
led to restoration of alveolar units as judged both histologically and by
overall reduction of physiological parameters indicative of emphysema:
high lung volumes and static compliance. Though it is unclear whether
the pathways of endothelial–epithelial crosstalk demonstrated post
pneumonectomy also apply to smoking-induced emphysema and vas-
cular remodeling, or recovery from it, both studies point to the potential
of the lung to generate new alveolar units.4. Conclusions and future directions
The concept of EMT has developed over time as activation of a
well-deﬁned transcriptional program with different outcomes during
embryonic development and as a response to injury or oncogenic trans-
formation in the adult. In this context EMT in the adult could be deﬁned
as a temporary or prolonged conversion of epithelial cells toward or to a
mesenchymal phenotype driven by one or more of the cardinal tran-
scription factors implicated in mesoderm development. By this deﬁni-
tion, activation of an EMT program appears common after signiﬁcant
epithelial injury. The available data suggest that EMT signaling is a phys-
iological and likely protective response to injury but the downstream
consequences of EMT signaling, such as resistance to senescence, prote-
ase expression, or ECM deposition, may also become pathogenic. In the
settings of tissue remodeling, in most cases it remains unclear exactly
how activation of an EMT transcriptional program is primarily directed
toward repair or propagation of ﬁbrosis. This remains an important area
of ongoing inquiry.
The association between activation of EMT signaling and epithelial
stem/progenitor cell function continues to be a consistently observed
phenomenon in several tissues, but remains of largely uncertain sig-
niﬁcance in the lung. Future studies exploring in more detail the func-
tional link between expression of the principal EMT transcription
factors within the epithelium and lung stem/progenitor cell function
will be important. At this point, the ﬁeld of lung repair is energized
by recent studies that further identify distinct stem/progenitor cell
populations in the airways and lung parenchyma and by new evi-
dence that lung regeneration may not only mean restitution of lost
epithelial barrier function but also de novo generation of new func-
tional units of gas exchange. It remains almost entirely unknown
what signals drive the expansion and/or organization of distal airway
and parenchymal epithelial progenitor cells after injury, to what
degree self-organization of such cells into new structures is ever func-
tionally relevant, and whether the regenerative potential observed in
mouse models of injury and repair extends to humans. Yet these
unknowns with clinical potential bring future mechanistic studies
of lung disease progression directly into the ﬁeld of regenerative
medicine.
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